Acceptability of rapid point-of-care hepatitis C tests among people who inject drugs and utilize syringe-exchange programs

Open Forum Infectious Diseases

Volumn 3, Issue 2, 2016, Pages

  Barocas, Joshua A ^a   Linas, Benjamin P ^b   Kim, Arthur Y ^a   Fangman, John ^c   Westergaard, Ryan P ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Hepatitis C screening; People who inject drugs; Rapid diagnostics; Syringe exchange programs

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; DRUG ADMINISTRATION; DRUG USE; FEMALE; HEALTH SURVEY; HEPATITIS C; HEPATITIS C RAPID TEST; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; MALE; MASS SCREENING; POINT OF CARE TESTING; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROGRAM ACCEPTABILITY; PUBLIC HEALTH; QUESTIONNAIRE; VISUAL ANALOG SCALE;

EID: 84995677053     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofw075     Document Type: Article

References (10)

1. Centers for Disease Control and Prevention (CDC). Syringe exchange programs-United States, 2008. MMWR Morb Mortal Wkly Rep 2010; 59:1488-91.
2. Hutchinson SJ, Bird SM, Taylor A, Goldberg DJ. Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: implications for prevention. Int J Drug Policy 2006; 17:211-21.
3. Centers for Disease Control and Prevention (CDC). Hepatitis C virus infection among adolescents and young adults: Massachusetts, 2002-2009. MMWR Mortal Wkly Rep 2011; 60:537-41.
4. Stockman LJ, Guilfoye SM, Benoit AL, et al. Rapid hepatitis C testing among persons at increased risk for infection-Wisconsin, 2012-2013. MMWR Mortal Wkly Rep 2014; 63:309-11.
5. Beckwith CG, Kurth AE, Bazerman LB, et al. A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections. J Public Health (Oxf) 2016; 38:130-7.
6. OraSure Technologies Inc. OraQuick HCV Rapid Antibody Test. Bethlehem, Pennsylvania.
7. Chapko MK, Dufour DR, Hatia RI, et al. Cost-effectiveness of strategies for testing current hepatitis C virus infection. Hepatol 2015; 62:1396-404.
8. Schackman BR, Leff JA, Barter DM, et al. Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs. Addiction 2015; 110:129-43.
9. Morano JP, Zelenev A, Lombard A, et al. Strategies for hepatitis C testing and linkage to care for vulnerable populations: Point-of-care and standard HCV testing in a mobile medical clinic. J Community Health 2014; 39:922-34.
10. Hayes B, Briceno A, Asher A, et al. Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs. BMC Public Health 2014; 14:645.